Wolf, P. A., Mitchell, J. B., Baker, C. S., Kannel, W. B. & D’Agostino, R. B. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch. Intern. Med. 158, 229–234 (1998).

Article  CAS  PubMed  Google Scholar 

Kornej, J., Börschel, C. S., Benjamin, E. J. & Schnabel, R. B. Epidemiology of atrial fibrillation in the 21st century. Circ. Res. 127, 4–20 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mou, L. et al. Lifetime risk of atrial fibrillation by race and socioeconomic status. Circ. Arrhythm. Electrophysiol. 11, e006350 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Elliott, A. D., Middeldorp, M. E., Van Gelder, I. C., Albert, C. M. & Sanders, P. Epidemiology and modifiable risk factors for atrial fibrillation. Nat. Rev. Cardiol. 20, 404–417 (2023).

Article  PubMed  Google Scholar 

International Diabetes Federation. IDF diabetes atlas 10th edn. International Diabetes Federation https://www.diabetesatlas.org (2021).

World Health Organization. Obesity and overweight. World Health Organization https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (2021).

Nattel, S., Burstein, B. & Dobrev, D. Atrial remodeling and atrial fibrillation. Circ. Arrhythm. Electrophysiol. 1, 62–73 (2008).

Article  PubMed  Google Scholar 

Zimetbaum, P. Antiarrhythmic drug therapy for atrial fibrillation. Circulation 125, 381–389 (2012).

Article  PubMed  Google Scholar 

Rettmann, M. E. et al. Treatment-related changes in left atrial structure in atrial fibrillation: findings from the CABANA imaging substudy. Circ. Arrhythm. Electrophysiol. 14, E008540 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lo, L. W. et al. The impact of left atrial size on long-term outcome of catheter ablation of chronic atrial fibrillation. J. Cardiovasc. Electrophysiol. 20, 1211–1216 (2009).

Article  PubMed  Google Scholar 

Oakes, R. S. et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119, 1758–1767 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Tsang, T. S. M. et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J. Am. Coll. Cardiol. 42, 1199–1205 (2003).

Article  PubMed  Google Scholar 

Hindricks, G. et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373–498 (2021).

Article  PubMed  Google Scholar 

Wijffels, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R. & Allessie, M. A. Atrial fibrillation begets atrial fibrillation. Circulation 92, 1954–1968 (1995).

Article  CAS  PubMed  Google Scholar 

Mant, J. et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370, 493–503 (2007).

Article  CAS  PubMed  Google Scholar 

Kirchhof, P. et al. Early rhythm-control therapy in patients with atrial fibrillation. N. Engl. J. Med. 383, 1305–1316 (2020).

Article  PubMed  Google Scholar 

Marrouche, N. F. et al. Catheter ablation for atrial fibrillation with heart failure. N. Engl. J. Med. 378, 417–427 (2018).

Article  PubMed  Google Scholar 

Rienstra, M. et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur. Heart J. 39, 2987–2996 (2018).

Article  CAS  PubMed  Google Scholar 

Pathak, R. K. et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J. Am. Coll. Cardiol. 65, 2159–2169 (2015).

Article  PubMed  Google Scholar 

Benjamin, E. J. et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271, 840–844 (1994).

Article  CAS  PubMed  Google Scholar 

Huxley, R. R., Filion, K. B., Konety, S. & Alonso, A. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am. J. Cardiol. 108, 56–62 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Staerk, L., Sherer, J. A., Ko, D., Benjamin, E. J. & Helm, R. H. Atrial fibrillation epidemiology, pathophysiology, and clinical outcomes. Circ. Res. 120, 1501–1517 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, A., Green, J. B., Halperin, J. L. & Piccini, J. P. Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J. Am. Coll. Cardiol. 74, 1107–1115 (2019).

Article  PubMed  Google Scholar 

Movahed, M. R., Hashemzadeh, M. & Mazen Jamal, M. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int. J. Cardiol. 105, 315–318 (2005).

Article  PubMed  Google Scholar 

Dublin, S. et al. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. J. Gen. Intern. Med. 25, 853–858 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Chao, T. F. et al. Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes. Int. J. Cardiol. 156, 199–202 (2012).

Article  PubMed  Google Scholar 

Zhang, Z. et al. Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis. BMC Cardiovasc. Disord. 17, 96 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Chang, S. H. et al. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies. Cardiovasc. Diabetol. 13, 123 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Zelniker, T. A. et al. Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial. Circulation 141, 1227–1234 (2020).

Article  CAS  PubMed  Google Scholar 

Liou, Y.-S., Yang, F.-Y., Chen, H.-Y. & Jong, G.-P. Antihyperglycemic drugs use and new-onset atrial fibrillation: a population-based nested case control study. PLoS ONE 31, e0197245 (2018).

Article  Google Scholar 

HC, G. et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. N. Engl. J. Med. 367, 319–328 (2012).

Article  Google Scholar 

Chung, M. K. et al. Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association. Circulation 141, E750–E772 (2020).

Article  PubMed  Google Scholar 

Wang, T. J. et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292, 2471–2477 (2004).

Article  CAS  PubMed  Google Scholar 

Lavie, C. J., Pandey, A., Lau, D. H., Alpert, M. A. & Sanders, P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. J. Am. Coll. Cardiol. 70, 2022–2035 (2017).

Article  PubMed  Google Scholar 

Frost, L., Hune, L. J. & Vestergaard, P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, Health Study. Am. J. Med. 118, 481–495 (2005).

Article  Google Scholar 

Krahn, A. D., Manfreda, J., Tate, R. B., Mathewson, F. A. L. & Cuddy, T. E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am. J. Med. 98, 476–484 (1995).

Article  CAS  PubMed  Google Scholar 

Huxley, R. R. et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 123, 1501–1508 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Lebek, S. et al. Enhanced CaMKII-dependent late INa induces atrial proarrhythmic activity in patients with sleep-disordered breathing. Circ. Res. 126, 603–615 (2020).

Article  CAS  PubMed  Google Scholar 

Tedrow, U. B. et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation: the WHS (Women’s Health Study). J. Am. Coll. Cardiol. 55, 2319–2327 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Jamaly, S. et al. Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish obese subjects. J. Am. Coll. Cardiol. 68, 2497–2504 (2016).

Article  PubMed  PubMed Central